GS-441524 (NeoFipronis) Price and Where to Buy
Feline Infectious Peritonitis (FIP) remains one of the most challenging diseases in feline medicine, caused by a mutated feline coronavirus. Traditional treatments have often been ineffective, but recent advancements have brought hope—particularly with GS-441524, marketed as NeoFipronis (Pronidesivir). This groundbreaking oral medication offers a promising solution for cats suffering from FIP, demonstrating high efficacy in alleviating symptoms such as anorexia, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomas, neurological damage, and uveitis.
NeoFipronis is the first FIP-specific oral drug officially approved in Laos by the Ministry of Agriculture and Forestry (MAF) in March 2026. Its registration as a medicinal product underscores its safety and efficacy. GS-441524, the active ingredient in NeoFipronis, has undergone extensive research and clinical trials, confirming its potent antiviral activity against FIPV (Feline Infectious Peritonitis Virus). The drug's quick absorption, minimal invasiveness, and low side effects make it a preferred choice for veterinarians and pet owners worldwide.
NeoFipronis is administered based on the cat’s weight, with a dosage of 15 mg per kilogram (equivalent to half a tablet). For neurological or ocular FIP forms, the dose may be increased up to 30 mg/kg under veterinary guidance. Treatment typically involves once-daily dosing, ideally on an empty stomach—either one hour before or two hours after a meal. The course should continue uninterrupted for a minimum of 12 weeks to maximize the chances of viral clearance and symptom resolution. During therapy, careful monitoring of the cat’s appetite, temperature, behavior, and overall health is vital, along with periodic blood tests to assess liver and kidney function.
While NeoFipronis is technically available as an over-the-counter medication in some regions, veterinary supervision remains highly recommended. Proper dosage, adherence to the treatment schedule, and regular check-ups are crucial for success. Owners should avoid discontinuing medication prematurely, as this could lead to relapse or incomplete recovery.
The safety profile of NeoFipronis, coupled with its ease of use, makes it an attractive therapeutic option. Its minimal side effects and straightforward oral administration contrast with more invasive or less effective therapies. This medication is formulated solely for feline use; human consumption is strictly prohibited. It is essential to purchase NeoFipronis through official channels to ensure product authenticity and quality.
Pricing and Purchase Locations
The price of NeoFipronis varies depending on the supplier, geographic location, and dosage size. Generally, a course of treatment may cost between $300 and $600, depending on the duration and the severity of the disease. Due to the high demand and limited availability in some regions, prices can fluctuate.
To purchase NeoFipronis safely, always buy through authorized veterinary pharmacies or official online platforms affiliated with the manufacturer. Avoid unverified sources or black-market sellers, as counterfeit or substandard products pose significant health risks. Many veterinary clinics now offer NeoFipronis directly or can guide pet owners to trusted suppliers.
For reliable purchasing, consult the official NeoFipronis website or contact veterinary professionals who are experienced in FIP treatment. With proper use and veterinary guidance, NeoFipronis has transformed many feline lives, providing a new outlook on managing this once-deadly disease.
In summary, NeoFipronis (Pronidesivir), containing GS-441524, is a highly effective, safe, and approved medication for feline FIP. Its proven antiviral results, ease of administration, and availability through verified sources make it a critical tool in contemporary feline medicine. Pet owners seeking treatment should prioritize consulting veterinary experts and sourcing the medication from trusted platforms to ensure optimum safety and treatment success.
